Publications & Collaborations

We work with leading international biopharma companies to accelerate the delivery of life-changing therapeutics to patients.

Our team has broad expertise in a range of disease areas, publishing in peer-reviewed journals and presenting at international conferences.

Biomarker analysis for a first-in-human trial of intraputamenal CDNF for Parkinson’s disease.

High-throughput mass spectrometry plasma proteomic analysis reveals stratification of responses to SARS-CoV-2 infection.

Mass spectrometry lipid profiling in a preclinical study of fetal gene therapy for neurodegenerative disease in infants.

A targeted multiplex proteomic CSF assay identifies potential diagnostic neurodegenerative biomarkers in people with Alzheimer’s disease.

The world’s first predictive multiplexed biomarker assay for severity of COVID-19 infection and outcome prognosis in a multi-cohort study.

Identification and validation of novel CSF biomarkers for neurodegeneration by a high-throughput multiplexed targeted proteomic assay.